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Södersjukhuset 
Karolinska Institutet, Stockholm, Sweden 
NEW ASPECTS ON TIMING AND GRAFT MORBIDITY IN ANTERIOR CRUCIATE LIGAMENT 
RECONSTRUCTION  





All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. 
Printed by US-AB 2020 
© Christoffer von Essen, 2020 
ISBN 978-91 -8016-043-8 






New aspects on timing and graft morbidity in Anterior 
Cruciate Ligament Reconstruction 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Christoffer von Essen 
Principal Supervisor: 
Associate professor Karl Eriksson 
Karolinska Institutet 
Department of Clinical Science and Education, 
Södersjukhuset 
Division of Orthopaedics 
 
Co-supervisor(s): 
MD, PhD Björn Barenius 
Karolinska Institutet 
Department of Clinical Science and Education, 
Södersjukhuset 
Division of Orthopaedics 
 
Opponent: 
Professor Jüri Kartus 
University of Gothenburg 




Professor Arkan Sayed-Noor 
Umeå University 
Department of Surgical and Perioperative Sciences 
Division of Orthopaedics 
 
Professor Joanna Kvist 
Linköping University 
Department of Health, Medicine and Caring 
Sciences 
Division of Prevention, Rehabilitation and 
Community Medicine 
 
Associate professor Per-Mats Janarv 
Karolinska Institutet 
Department of Department of Molecular Medicine 
and Surgery 





























To Nina and Poppy 
  
ABSTRACT 
The aim of this thesis was to investigate the effect of different surgical techniques on knee 
function and outcomes after an anterior cruciate ligament (ACL) reconstruction (ACLR). 
In Study I, 70 patients with a Tegner level of six or more were assessed after randomisation 
between acute ACLR (within 8 days after the injury) and delayed ACLR (after normalised range 
of motion [ROM] 6–10 weeks after the injury) using a four-strand semitendinosus tendon graft. 
The primary endpoint was range of motion at three months, and in this first study the patients 
were followed up for six months. The results for stiffness, laxity, functional tests and functional 
scores were comparable for both groups. Patients who underwent delayed surgery had more 
muscle hypotrophy in the early phase of the rehabilitation process.  
In Study II, 70 patients from the same randomised controlled trial as in Study I were assessed to 
compare total number of sick-leave days taken during the first year following an ACL rupture in 
those undergoing acute and delayed reconstruction as a means of measuring indirect 
socioeconomic costs. Acute reconstruction resulted in significant fewer sick-leave days during 
the first year after the injury. Acute and delayed ACL reconstruction provided similar clinical 
outcomes after 12 months with no significant differences. 
In Study III, the patients in Study I were assessed at 24 months post-surgery. Twelve patients 
were lost to follow-up, six in each group. While no significant differences regarding outcome 
measurements between the groups could be found, both groups showed better functional 
outcome scores compared to the Swedish Knee Ligament Register (SKLR).   
In Study IV, 140 patients were randomised between ipsilateral (IL) and contralateral (CL) four-
strand semitendinosus tendon autograft and followed up for 24 months. The aim was to compare 
muscle strength and patient reported outcomes following ACLR using a semitendinosus (ST) 
graft from the IL leg compared to a graft from the CL leg and the primary endpoint was 
isometric hamstring strength at 6 months The results did not show any measurable subjective 
differences. The CL group showed early symmetrical strength between the limbs, while the IL 
group stayed asymmetrical during the whole trial with significant differences between the 
groups in both isometric and isokinetic strength.  
In conclusion, acute ACLR can be performed safely without an increased risk of developing 
stiffness, and a reconstruction performed before recurrent giving ways occur increases the 
likelihood of achieving better functional scores. There is also, from a society viewpoint, a 
potential economic benefit to identifying individuals who would benefit from acute ACL 
reconstruction. Using a CL autograft is a safe option and could have benefits regarding regaining 
symmetrical strength between the limbs  
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The anterior cruciate ligament (ACL) prevents the anterior translation of the tibia in regard to 
the femur as well as the rotation of the tibia. Although a rupture of the ACL frequently 
happens in contact sport, such as football (US: soccer), it often occurs without contact1. The 
result of an ACL injury is commonly an unstable knee joint where the instability could lead 
to episodes of ‘giving way’. Some people with a torn ACL do not experience instability or 
‘giving way’ they are typically referred to as ‘copers’. However, most of these persons 
modify their activity and are therefore named ‘adapters’2. The ‘non-copers’ are those who 
cannot return to their previous activity level due to the instability caused by the ruptured 
ACL. With a torn ACL, there is a risk for recurrent ‘giving ways’ and secondary injuries, 
such as meniscus or cartilage lesion, as well as other ligament injuries3-5. Among active 
patients, the rate of ‘true copers’ seems to be low. Frobell et al. did a randomised controlled 
trial (RCT) comparing operative and conservative treatment, and had conservative-to-
operative crossover rate of more than 50%, and in a study by Hurd et al.,who had developed 
an algorithm to classify highly active patients as potential copers, found that within 10 years 
of the ACL rupture, 83% of the potential ‘copers’ had undergone anterior cruciate ligament 
reconstruction (ACLR)6 7. Therefore, ACLR is the preferred treatment for active patients who 
wish to return to sport (RTS), and in my opinion it should be performed as soon as possible to 





2.1 ANATOMY OF THE ACL 
The knee, or the tibiofemoral joint, is a hinged joint formed between the femur, tibia and 
patella and involves both rotation and translation. The surfaces of the joint are covered with a 
layer of hyaline cartilage, which gives the bones a smooth surface and protects the bone. 
Between the femur and tibia are the menisci, which act as shock absorbers and stabilisers in 
the knee8 9. The knee is dynamically stabilised by muscles and ligaments to hold it in proper 
alignment.  
The ACL is one of four ligaments of the knee, and its primary role, working together with the 
posterior cruciate ligament (PCL), is to prevent the anteroposterior displacement of the tibia 
on the femur and secondarily to provide rotational stability10.  
The ACL is an intraarticular extrasynovial structure, originating from mesenchymal cells, and 
is richly vascularised from the middle genicular artery11 12. It consists mainly of parallel 
collagen 1 fibres and a matrix of different glycoproteins, making a complex, elastic system, 
allowing it to withstand tension and load13. As all people are unique, the anatomies of the 
ACL differ from knee to knee. The ACL has an average length of 32 mm with an average 
diameter of 11 mm14 and runs from the anterior intercondylar spine of the tibia to the medial 
wall of the lateral femoral condyle15. Although regarded as one ligament, the ACL is often 
described as consisting of two bundles, the anteromedial (AM) and posterolateral (PL)16 17. 
The femoral insertions of the AM and PL bands are often separated by a bony landmark, the 
bifurcated lateral ridge, which, together with the intercondylar ridge, is used to identify the 
anatomical position for the femoral tunnel in ACLR. Both the AM and PL prevent anterior 
translation and internal and external rotation of the tibia in relation to the femur, with the AM 
band more tense from 30° to 90° and the PL from 0° to 30° of knee flexion15 18. Studies have 
showed that the AM bundle is superior to the PL bundle in terms of anteroposterior and 
rotational stability19 20. A fact worth considering when choosing the tunnel positioning during 
ACLR. 
2.2 EPIDEMIOLOGY 
The incidence of ACL injuries varies between 68–80 per 100 000 persons per year in Sweden 
and worldwide21-24, and it is suggested that around 50% of ACL injuries in Sweden undergo 
surgery25. The most common age group for ACLR is 15–19 years1, and even though it has 
been reported that females have a higher risk for ACL injuries26 27, males are overrepresented 
in terms of reconstruction1.  
The vast majority (80%) of ACL injuries happen in non-contact situations, especially cutting 
or landing28-30, and football is the most common sport1. Koga et al. used a model-based 
image-matching technique and concluded that the injury occurs close to full knee extension 
(i.e. axial compression) in combination with valgus force31. Quadriceps contraction has also 
been suggested as a potential contributor to ACL injuries30. As a result, there has been a 
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development of prevention exercises and neuromuscular training programmes, which have 
proven to be effective in reducing ACL injuries32-34.  
An ACL injury is seldom isolated; concomitant structural injuries, such as the menisci, the 
collateral ligaments or the cartilage, are affected in up to 88% of these injuries35. 
2.3 CLINICAL ASSESSMENT OF ACL INJURIES 
While magnetic resonance imaging (MRI) is a valid and non-invasive diagnostic method to 
find the injury (specificity and sensitivity of 94–98%)36 37, it is also relevant to assess a 
suspected ACL injury by evaluating the increased anteroposterior laxity as well as the 
rotational knee laxity.  
The most commonly used physical examinations are described as follows. 
The Lachman test 
The Lachman test, with reported sensitivity values ranging from 0.63–0.93 and specificity 
values ranging from 0.55–0.9938, is performed with the patient’s knee in 30° of flexion and is 
assessed relative to the contralateral (CL) knee. The tibia is pulled forward to assess the 
amount of anterior translation of the tibia. An intact ACL should prevent forward 
translational movement, while an ACL injury will demonstrate increased anterior translation 
without an endpoint. A difference between the legs of more than 2 mm indicates an ACL 
injury39 40. To quantify the anteroposterior laxity, the most common devices are the KT-1000 
and the Rolimeter, both of which can be used to determine the movement in millimetres41 42. 
The anterior drawer test 
The test is performed with the patient in the supine position with the hip flexed to 45° and the 
knee flexed to 90° with the feet flat on the ground. The examiner tries to translate the tibia 
anteriorly to the femur. The test is positive if there is a side-to-side difference. The test has 
high sensitivity and specificity in chronic conditions but not in acute conditions39, reported 
sensitivity values ranging from 0.18–0.92 and specificity values ranging from 0.78–0.9838. 
The pivot shift test 
The test is performed by applying valgus stress and axial load while internally rotating the 
tibia as the knee is slowly moved from extension to flexion. This test is considered positive if 
the proximal tibia subluxes anteriorly on the distal femur at about 30° of flexion44. The test 
has a sensitivity of 0.18 to 0.48 and a specificity of 0.97 to 0.9938. However, the grading of 
the pivot shift test is highly subjective due to impossibility of comparing grading between 





The aim of any treatment of an ACL injury is to reduce the feeling of instability and to 
restore the function of the knee. The treatment can be surgical or non-surgical, both with 
rehabilitation.  
Who will benefit from ACLR is still debated as the long-term outcome after ACLR compared 
to conservative treatment has not been proven to be better6 47 48. Many patients never go back 
to their pre-injury activity level, and many patients develop osteoarthritis (OA) of the knee 
irrespective of treatment4 49-52. However, it is well established that ACLR decreases 
pathologic laxity and reduces episodes of instability5 6 53.  
A general opinion is that high-level athletes, in particular those engaging in pivoting sports, 
are likely to benefit from ACLR as well as those suffering from recurrent ‘giving ways’, 
hence persons having a higher risk for subsequent meniscal or chondral injuries25 54. 
Frobell et al.6 47 published a randomised controlled trial (RCT) on the subject, comparing 
initial ACL reconstruction with rehabilitation alone and a choice of later reconstruction. They 
found no differences between the groups and therefore concluded that rehabilitation alone 
should be regarded as the primary treatment after an ACL injury, but these findings need to 
be viewed in the context that nearly 50% of the participants with an ACL rupture remained 
symptomatic following rehabilitation and later opted for ACLR. Similarly, a recent Cochrane 
review concluded that there is not enough evidence to suggest that the two options are equally 
effective55. 
 
2.4.1 Surgical treatment 
2.4.1.1 Position of the graft 
The main problem for the patient is instability, so the main goal of ACLR is restoring normal 
stability56. A few decades ago, at the beginning of the arthroscopic ACLR era, a transtibial 
(TT) approach for reconstructing the ACL was used, and the objective was an ‘isometric’ 
position, where the aim was to achieve the same tension force on the graft at all angles. This 
meant placing the graft in a more non-anatomical vertical position, with a posterior placement 
of the tibial tunnel and the femoral tunnel both high and posterior57 58; however, this position 
did not to the same degree restore rotational stability59. This led to a transition to instead 
strive for an anatomical replacement of the ruptured ACL using an accessory AM portal for 
reaming the femoral tunnel. This can be done by either a single-bundle (SB) or a double-
bundle (DB) technique, where the DB tries to mimic the ACL according to its AM and PL 
bundles. Both these techniques restore the kinematics in the knee 60-62 and have also proven to 
be better than the TT technique in improving rotational stability33 34 63 although studies do not 
show that the DB procedure restores rotational stability better than the SB procedure57 64-66. 
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2.4.1.2 Grafts used in ACLR 
The most widely used autografts for reconstruction of the ACL include the patellar tendon 
(BPTB), the hamstring tendon (HT) and the quadriceps tendon (QT), all of which have their 
own advantages and disadvantages. There are numerous studies that have evaluated the 
results between the three, but for the most part, they show comparable results in terms of 
successfully stabilising the knee67-70, but BTBP grafts are considered to create more donor 
site morbidity compared to HT grafts71-73. In addition to autografts, there is also the option for 
allografts. 
Additionally, studies examining which graft to choose have found that the surgeon’s 
recommendation was the primary influencer74 75. 
The BPTB autograft is still considered the gold standard in ACLR76 77, but at least in Sweden 
the HT has replaced it as the most commonly used graft21.  
Patella tendon (BTPB) autograft 
Among the advantages of the BTPB is the ease of harvest, and the bone plugs at both ends 
facilitate graft fixation. Its most significant disadvantage is donor site morbidity. Anterior 
knee pain is common with BTPB, at around 50%, and kneeling pain, around 65%, at two-
year follow-up78 79. An extension deficit can be seen up to three years postoperatively, but all 
of these morbidities usually disappear over time78. Other rare complications are patella 
fractures (incidence 0.4–1.3%) and patella tendon ruptures (incidence 0.18–0.25%)70.  
Hamstring tendon (HT) autograft 
HT grafts are mostly reported based on the number of strands included in the grafts and can 
be further classified into semitendinosus and gracilis (STG) or just semitendinosus (ST). The 
extent to which HT graft size matters in regard to failure rate is still unclear; evidence 
indicates that the graft diameter should be at least 8 mm80-82, and two studies showed a linear 
correlation that the likelihood of revision surgery decrease with every 0.5-mm increase of 
diameter in the HT graft size up to a graft size of 10 mm82 83.  HT also has some donor site 
morbidities, which include both sensory and strength deficits. The sensory deficit is typically 
related to the incision, where branches of the saphenous nerve is easy to disrupt84. The main 
drawback of HT harvesting is the considerable deficit in knee flexion and tibial internal 
rotation strength85 and might therefore be less suitable for patients dependent on deep flexion 
strength, such as wrestlers, gymnasts and other high-level athletes. The HT will in most cases 
regenerate after harvest although functional deficit may persist for at least two years84 86-89. 
The ST and G tendons insert at the pes anserinus region, and if they do not regenerate at full 
length, the biomechanics in the knee might change.  
Quadriceps tendon (QT) autograft 
QT has gained popularity in recent years90. Harvest of the QT can be done with or without a 
bone block, and the morbidity has been reported as low73. The most commonly reported 
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morbidities are anterior knee pain and strength deficit, and more rare reports include bleeding 
and haematoma formation, cosmetic deformities of the distal thigh and patella fracture73 91. In 
a systematic review, the anterior knee pain was less frequently seen with QT compared to 
BPTB, and in regard to strength, there was no difference between QT and BPTB. 
Additionally, QT had greater flexion strength over HT but less knee extension strength91.  
Allograft 
An allograft is a tissue transplanted from another person. In Europe, the allograft is not 
routinely used for primary ACLR, but it is common in the USA92. There are also indications 
of less stability and higher failure rates after ACLR with allografts, especially in the younger 
population93 94.  
Contralateral (CL) graft 
Clinical observation when using the CL leg for donor graft with revisions of ACLR has 
raised the possibility to use it as a good donor candidate for primary reconstruction95-98. The 
CL BPTB has been widely used and studied for primary reconstruction with good results98-
100. However, as for CL HT, the first reported study was by Yasuda101, who mainly aimed to 
distinguish the morbidity caused by STG harvest. To my knowledge, the only other study 
undertaken on this subject is an RCT by McRae et al.102, also using STG; however, this study 
could not demonstrate any drawbacks or benefits. 
Andernord et al. studied the association of harvest site and the future need for CL 
reconstruction and found an increased risk among female patients who underwent ACLR 
with a CL HT graft96. One explanation could be that females depend more on their hamstring 
performance on the ACL than their male counterparts103. However, there were few patients, 
and no other study has showed the same association.  
 
2.5 WHEN IS THE RIGHT TIME TO PERFORM ACLR? 
At the beginning of the ACLR era, ACLR was considered an acute procedure104 105, but at the 
beginning of 1990s, Shelbourne and colleagues106 107 evaluated the effect of the timing of 
surgery after acute ACLR and found a significant increase in arthrofibrosis(AF) in patients 
who underwent surgery within the first week of injury. This led to a paradigm shift that is 
largely still in effect today. According to this paradigm, ACLR should be performed when 
ROM has normalised, usually at least three weeks after injury108. However, several studies 
have shown a similar postoperative ROM regardless of when surgery was performed109-111. 
Sweden has embraced a treatment algorithm, which means that most patients first receive 
non-surgical treatment, thereby extending the time to surgery112. This is in line with the 
studies by Frobell et al.6 47. An advantage of delaying surgery is that the patients can prepare 
for the reconstruction and establish realistic recovery goals and, so-called ‘copers’ can also be 
identified. However, there is evidence that early ACLR can facilitate better results, including 
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earlier RTS and work, and has been reported to be more cost effective, while there is also 
evidence that increased time between injury and surgical intervention is associated with an 
increased incidence of concomitant injuries3 5 113-119. 
There is, however, no clear definition in regard of the time from injury to reconstruction what 
early or delayed reconstruction is. This lack of definition is leading to conflicting evidence of 
risks and benefits. Andernord et al. pointed out in a systematic review that early ACLR 
ranged from two days to seven months, while delayed ranged from three weeks to 24 
months109. Other, more recent meta-analyses also had broad or overlapping cut-offs120 121, 
which makes it impossible to draw any conclusions regarding timing. Two other recent meta-
analyses, which had a clearer definition of acute and delayed reconstruction, within three 
weeks as according to Shelbourne, could not find any differences between the groups122 123. 
2.6 OUTCOME 
While the surgeon rates success from objective measures, such as laxity, ROM and muscle 
function, the subjective measures from the patient’s perspective are usually assessed via 
questionnaires, often referred to as patient-reported outcomes (PROs). As there are more than 
54 outcome scores for ACL ruptures124, it is important to use those that are validated and 
possible to compare with other studies. One of the first validated forms was the International 
Knee Documentation Committee (IKDC) form, designed in 1982 and which has had 
widespread use since then125. Health-related quality of life (HRQoL) questionnaires were 
developed for self-administration, and the one used the most within ACL research is currently 
the Knee Injury and Osteoarthritis Outcome Score (KOOS), which is specific to knee injuries 
and is validated and used in the SKLR as an outcome measure126 127. While a certain score in 
KOOS might be satisfactory for the surgeon, it does not have to correlate to the patient’s 
wellbeing. Therefore, Barenius et al. suggested threshold values for what they defined as 
functional recovery (FR), and these values were based on the lower threshold for 95% 
confidence interval of 18–34-year-old males in a Swedish reference population two years 
post-surgery128. Another study by Muller et al. defined threshold values for what they named 
patient-acceptable symptom state (PASS), and the values were defined by a study population 
of 251 patients answering the question – ‘Taking into account all the activity you have during 
your daily life, your level of pain, and also your activity limitations and participation 
restrictions, do you consider the current state of your knee satisfactory?’ – one to five years 
after ACLR129. The values for the subscales differ between PASS and FR and thresholds are 
not interchangeable. While FR is equivalent to a return to a nearly pre-injury KOOS level, 
hence harder to obtain, PASS is a measure of what the patient finds an acceptable state. In the 
national cohort by Barenius, only one-fifth of the patients were in FR after two years, while 
in a recent study by Cristiani et al., more than 60% reported PASS on four of the five 
subscales in KOOS128 130. Another study, by Ingelsrud et al., conducted similar research in 
which they asked patients from the Norwegian knee ligament register about their acceptable 
symptom state131. The patients were categorised into three groups – those with acceptable 
symptoms, those who felt that their treatment had failed and a third category for those who 
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were indecisive. This study showed acceptable symptoms in 66%, even if the cut-offs used in 
this study were similar to the ones in Barenius study for pain, symptoms and ADL they were 
lower for Sport/Rec and QoL. For QoL a score of 72 would be enough to reach an acceptable 
state compared to 81 in the study by Barenius. One reason for this could be that Barenius 
only extracted data from the register, whereas the Norwegian study asked the question 
directly. For PROs, Ingelsrud also confirmed that the subscales for Sport/Rec and QoL are 
the most important and defined the minimal important change (MIC) after ACLR. In a study 
from 2018, they found that that the MIC values for Sport/Rec and QoL were 12 and 18, 
respectively132.  
While treatment failure (TF) is as important as success, it has been a bit overlooked in the 
literature. In the Barenius study, the cut-off value for TF was set as subscale QoL < 44. This 
value is from a study by Frobell, randomising between surgical vs non-surgical treatment 
after an ACL injury47. The value of 44 was one criterion for crossover from non-surgical to 
surgical treatment. In the cohort by Barenius, 30% of the patients were defined as TF. In 
Ingelsrud’s study, the KOOS subscale QoL value for TF was < 28, and therefore only 13% in 
this cohort study was regarded as TF131.   
2.6.1 Rerupture rate and CL injuries 
An ACL graft tear or a CL ACL injury is detrimental to patient outcomes following ACLR. 
From the results of systematic reviews, one can expect a failure rate between 3.5 and 7% of 
the autografts133-135. Younger patients, especially adolescents, run an even higher risk of 
another ACL injury136 137. There may be many reasons for this although younger patients RTS 
with frequent pivoting movements, such as football, at a higher rate than older patients137 138. 
By exposing the knee to a higher degree of pivoting movements, the knee will be at a higher 
risk of an injury and could explain why younger patients run a greater risk for a subsequent 
ACL injury. In a more recent study, Grindem et al. concluded that age itself was not 
associated with a second ACL inury139. They found that, independent of age, return to high-
level pivoting sports within the first year resulted in a six-times-higher risk for another ACL 
injury and that younger patients are more likely to return to this activity level and therefore 
ran a higher risk for a rerupture. By making sure the patients had gained symmetrical strength 
and delaying the return for at least nine months, the risk for a rerupture decreased140. 
Although females run a higher risk for a primary ACL injury, studies have not shown sex to 
be a risk factor for a reinjury138 141 142. This could be explained by the fact that women seem to 
return to a lower level of activity143. The exact rate of re-tears is difficult to determine as there 
are many unrecorded – some might cope with occasional giving-way, while others are no 
longer as active as before and therefore are not bothered by the graft rupture. Most graft 
failures occur during the first year after reconstruction, which could be due to an inadequate 
incorporation process of the graft144 145.  
Revision surgery could be another outcome measure as it might represent patients with 
clinical symptoms of a re-tear. The rates of revision surgery have been reported at 2–3% 
within the first two to three years146 147 and an overall revision rate of approximately 4% in 
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both the Danish ACL Reconstruction Register and SKLR146 148. Sadly, the outcome after a 
revision surgery is often less successful149.  
In terms of CL ACL injury, the numbers are between 12–14%133 135 150. It often occurs during 
the first three years after the first ACLR, and risk factors are age, sex and activity at the 
primary ACLR96 144 150 151.  
2.6.2 Return to sport (RTS) 
The majority of patients undergoing ACLR are active in sports and want to return to their 
pre-injury activity level although this is not a guarantee even after surgery. A recent meta-
analysis by Ardern et al.143 reported that only two-thirds manage to return to their previous 
level, however 82% returned to some type of sport participation. Other systemic reviews 
looking at high-performance athletes showed that most returned to their pre-injury level, with 
rates varying between 78 and 90%152-154.  
2.7 ARTHROFIBROSIS 
Arthrofibrosis (AF) is abnormal internal scarring inside the joint and can occur in almost any 
joint155. The fibrotic scarring is caused by an inflammatory response, leading to an 
uncontrolled myofibroblast proliferation with reduced normal aptosis. This in turn makes a 
lot of extracellular matrix composed of collagen, which causes sticky adhesion and contracts 
tendons and bursa and makes the knee lose its ROM156. Why AF occurs is still unknown but 
seems to have a physical trigger, such as surgery, and certain procedures have an increased 
risk, especially ACLR157 158. The incidence of AF after ACLR ranges between 2 and 35%, 
and the difference might be the lack of uniformity in defining AF157 158. Shelbourne et al. 
developed the most common classification in use in 1996. They defined AF as a 5° loss of 
extension and proposed a classification system based on flexion and extension loss159 (see 
Table 1). An international panel of experts developed a more recent classification in which a 
restricted ROM in flexion or extension or both must be present for a diagnosis of AF160. The 
severity is then graded according to loss of movement based on the deviation from full 
flexion or extension as mild, moderate and severe flexion range (90°–100°, 70°–89°, < 70°) 
and/or extension restriction (5°–10°, 11°–20°, > 20°)160. Mayr et al. proposed another 
classification; AF should be defined if scar tissue is found in at least one compartment of the 
joint and affects the ROM161. These definitions are objective cut-offs, but other studies use 
subjective restriction of ROM as a definition of AF, which makes it unclear the severity of 
the AF and therefore hard to review the literature and to determine risk factors for AF162. 
Other reasons for ROM problems can be poor surgical technique, poor graft positioning and 
inappropriate width of the graft158. The aim of investigating a patient with a stiff knee after 
surgery is to exclude other causes of stiffness. CT or plain radiography can show 
malpositioning or patella infera. An infection should also be excluded. MRI can show scar 
tissue but is not totally reliable in the diagnosis of AF160. If there are no other causes of 
stiffness, an arthroscopy may be performed to support the clinical diagnosis. Patients 
requiring intervention range from 0.5% to 5.4% in different studies, and females carry a 
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higher risk158 163 164. One could define AF as early, within 3–6 months, or late, > 6months, and 
treatment depends on this. If motion loss develops early, NSAID and/or intra-articular steroid 
injections can be used, and a trial of intensive physiotherapy might help in regaining ROM165. 
If this fails, manipulation under anaesthesia (MUA)165 can be performed. Patients with late 
AF or patients resistant to non-operative treatment usually require arthroscopic treatment160 
166.  
Table 1: Classification of arthrofibrosis  








Type 1 <10° None No No 
Type 2 >10° None No No 
Type 3 >10° >25° Yes No 
Type 4 >10° ≥30° Yes Yes 
Adapted from Shelbourne et al.159 
A ‘cyclops lesion’ is special localised fibrosus noduli which occur in the intercondylar notch 
with a pattern histologically different than that of AF and should therefore not be mistaken 
for AF167. The incidence range from 1.9–10.9% and can occur after ACLR and can cause 
knee extension loss168. It has been suggested that the debris from the tibia tunnel or 
microtrauma to the graft stimulates cyclops lesions169. A recent systematic review identified 
knee stiffness before ACLR, a narrow intercondylar notch and a tibial tunnel position too 
anterior as risk factors for developing cyclops lesions168. A cyclops lesion, if symptomatic, is 
treated with arthroscopic removal158 167 and can be detected with MRI170 
2.8 OSTEOARTHRITIS (OA) 
Patients with an ACL injury run a much higher risk of developing post-traumatic OA over the 
long term, up to 20 years from injury; a 10-fold increased risk has been reported4 171. Studies 
also show that meniscus injuries are associated with a higher rate of secondary OA4 172-174. 
There are reports suggesting that meniscus sutures to some extent prevent secondary OA175 
176. Even though no treatment for an ACL injury has shown to reduce the risk for OA, there 
are indications that factors protecting the knee from subsequent injuries, such as early 
ACLR54, and an increased focus on saving the meniscus176 might be beneficial in reducing 
the risk of secondary OA177. It will be interesting to see what the future holds.  
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2.9 HEALTHCARE SYSTEM AND SOCIOECONOMICS 
Healthcare in Sweden is largely tax-funded and decentralised. It is a system where everyone 
has equal access to healthcare services. The central government, country councils and 
municipalities are in charge of and responsible for the healthcare services. The coverage is 
extensive, and patients only pay small fees when visiting a doctor, with a maximum of 1,100 
SEK per 12 months. Private healthcare is also available but is rather small although 
expanding each year.  
If a person cannot work in Sweden due to sickness or injury, he or she can obtain 
compensation with a sick leave benefit. The system is regulated by Swedish law and for the 
first day of illness, a qualifying deduction is made which corresponds to 20 % of a normal 
week’s salary. After this first day one will obtain sick pay. As an employee, you receive sick 
pay from your employer up to and including day 14; after that, the money comes from the 
Swedish Social Insurance Agency (Försäkringskassan). The patient needs to submit a medical 
certificate to his or her employer after one week. There is, however, a time limit for sick leave 
pay; during the first 90 days, the patient is entitled to the pay if he or she is unable to cope 
with their normal work. For the next 90 days, the patient can get sick leave pay if he or she is 
unable to cope with their normal work or any other work the employer can offer. The sick 
leave pay is usually 80% of the worker’s salary, with a maximum of 804 SEK per day, but 
many employers offer a form of insurance to ensure a higher salary if a person gets sick178.  
To evaluate the cost effectiveness of a treatment, quality-adjusted life-year (QALY) can be 
used. QALY was developed to facilitate comparison between treatments or interventions. By 
converting a treatment to a common unit, comparison can be made in terms of cost per 
standardised effect. QALY measures the benefit of an intervention to a patient over their 
lifetime; it measures the years a patient might gain as well as the quality of life during those 
years179. Further, taking into account to the total cost and the outcomes associated with the 
treatment (QALY gain) provides a value of cost per QALY. This makes it possible to 
compare treatments based on the total costs of their outcomes, and different countries have 
different threshold values of what counts as cost-effective179.  
As ACL tears usually affect young people, there are large potential economic losses when 
suffering an injury. Although it is hard to generalise studies due to differences in healthcare 
systems, there are studies showing that ACLR seems to be more cost-saving and cost-
effective than rehabilitation113 180 181. In a recent study comparing competitive athletes, the 
incremental cost-effectiveness ratio of ACLR was approximately $22,000 per QALY 
gained182. 
2.9.1 Sick leave in other countries 
Sick pay and sick leave vary from country to country. Some countries require employers to 
pay for the sick leave days (Australia, the Netherlands, New Zealand, Switzerland and the 
United Kingdom), while others have a social insurance system that covers sick pay using tax 
revenue (Canada, France, Ireland, Italy and Japan). Most countries use a combination of 
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employer mandates and social insurance (Austria, Belgium, Denmark, Finland, Germany, 
Greece, Iceland, Luxembourg, Norway, Spain and Sweden). A waiting period is often 
employed, ranging from one to nine days, and represents a period where no money is paid 
out. There are also forms of insurance that can entitle the patient to more sick leave and other 
benefits.183 
Among the more generous countries is the Netherlands, where workers can be absent up to 
104 weeks and receive 70% of their salary for the whole period. The employers are obliged to 
cover that cost during the whole period, but not longer than the duration of the contract. There 
is also an upper ceiling of €200 per day. German workers are entitled to 100% of their 
earnings for the first six weeks and 70% thereafter. The first six weeks are covered by the 
employer and the rest by the state183.  
In the UK, employees have no statutory right to receive their contractual pay during time 
spent away from work on sick leave. They may, however, have a right to receive statutory 
sick pay (‘SSP’) at a fixed amount set by the government, which is currently £95.85 per 
week, with the first three days unpaid up to 28 weeks184. 
There is no national requirement in the USA to offer paid sick leave though many states have 
their own laws on this. However, the Family and Medical Leave Act (FMLA) requires 
companies with more than 50 employees to allow them unpaid time off for medical leave or 
to care for a family member. The rules and regulations vary for different states. For example, 
workers in Massachusetts receive one hour of paid sick time for every 30 hours they work. 
Workers in New York are given 40 hours of paid sick leave per year. Alternatively, in a 
minority of jurisdictions (for example, California, Connecticut and Massachusetts), 
employers are required to provide paid sick leave for employees185.  
As for Australia, employees are entitled to 10 days of leave each year, and if the worker does 
not use the days, they carries over into the next year. Employees also can take unpaid sick 





The overall aim of this thesis was to investigate the influence of different surgical strategies 
on the outcome after ACLR.  
3.1 STUDY I 
The aim of the study was to determine if it is safe to reconstruct the ACL within eight days 
after the injury compared to delayed ACLR after normalised ROM 6–10 weeks after the 
injury. The primary endpoint was ROM at three months.  
Secondary aims were to compare early functional outcomes between the groups. Physical 
examination, instrumented laxity, functional scores and Lysholm and KOOS measured the 
outcome. 
3.2 STUDY II 
The aim of the study was to compare the total number of sick-leave days taken the first year 
following an ACL rupture in those undergoing acute and delayed reconstruction as a means 
of measuring socioeconomic costs. 
Secondary aims were to compare early functional outcomes between the groups at 12 
months.  
3.3 STUDY III 
The aim of the study was to compare acute ACLR within eight days of injury with delayed 
reconstruction after normalised ROM 6–10 weeks after injury in regard to outcomes when 
assessed at a minimum of 24 months post-surgery. 
3.4 STUDY IV 
The aim of the study was to compare ACLR using ST graft harvested from the ipsilateral (IL) 
leg compared with those where the ST graft is harvested from the CL leg. The primary 
endpoint was isometric hamstring strength at six months.  
Secondary aims were to compare patient-reported and functional outcomes between the 
groups over 24 months. Physical examination, instrumented laxity, functional scores and 
Lysholm and KOOS measured the outcome
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4 STUDY POPULATION 
4.1 STUDIES I–III 
Between 2006 and 2013, 70 patients were included in a one-centre RCT. Patients presenting 
at the emergency department with a severe knee injury were assessed with MRI within three 
days of the injury. If there was an ACL injury, the patient was evaluated for participation in 
the trial. A total of 920 patients were assessed for eligibility. Inclusion criteria were primary 
unilateral ACL rupture, age between 18 and 40 years and no previous injury on the involved 
or CL knee. Further criteria were no additional injuries on MRI indicating a need for an acute 
procedure nor PCL-insufficiency, LCL or MCL injury greater than grade one and no sign of 
OA. The study was designed to include patients with a high demand for stability in the knee; 
therefore, an inclusion criterion was a Tegner activity level of at least six, which is 
recreational sport (tennis, alpine skiing, etc.).  
If the patient fulfilled the prerequisites, a research nurse performed the randomisation with 
sealed envelopes in batches of 20, and the patients were randomised to ACLR within eight 
days of injury or delayed reconstruction after normalised ROM 6–10 weeks after the injury. 
The demographics of the study groups are presented in Tables 2–3. One patient dropped out 
before reconstruction in the delayed group due to waiting time. Preoperatively, there were no 
significant differences between the study groups. Both groups were similar in terms of 
gender, age at the time of surgery and the number and type of associated injuries.  
 










Age at inclusion mean ±SD 26.9 ± 6.1 27.7 ± 6.5 26.1 ± 5.7 n.s. 
Gender: females n (%) 21 (31) 10 (30) 11 (31) n.s. 
Height cm mean ±SD 177 ± 9 177 ± 9 178 ± 9 n.s. 
Weight kg mean ±SD 77 ± 11 76 ± 11 78 ± 12 n.s. 
Smoker n (%) 4 (6) 2 (6) 2 (6) n.s. 
Highest education n (%)    n.s. 
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High school/college 35 (55) 20 (65) 15 (45)  
University 29 (45) 11 (35) 18 (54)  
Type of activity when injured 
n (%) 
   n.s. 
Football 27 (38) 14 (41) 13 (37)  
Indoor floorball 16 (24) 6 (18) 10 (29)  
Alpine ski/snowboard 10 (15) 7 (20) 3 (8)  
Handball 5 (7) 1 (3) 4 (11)  
Wrestling/MMA 3 (5) 3 (9) 0  
Gymnastics 2 (3) 2 (6) 0  
Ice hockey 1 (2) 0 1 (3)  
Am. football 1 (2) 0 1 (3)  
Badminton 1 (2) 0 1 (3)  
Basketball 1 (2) 0 1 (3)  
Dance 1 (2) 1 (3) 0  
Tennis 1 (2) 0 1 (3)  





Table 3: Demographics 





Time injury-recon d ± SD 5 ± 2 55 ± 8 < 0.01 
OP time min ± SD 93 ± 20 83 ± 18 n.s. 
Graft diameter mm ± SD 8.8 ± 0.8 8.6 ± 0.8 n.s. 
Additional injury n (%) 21 (66) 15 (47) n.s. 
Medial meniscus n (%) 7 (21) 2 (6) n.s. 
Lateral meniscus n (%) 13 (39) 10 (29) n.s. 
Sutures n (%) 3 (9) 1 (3) n.s. 
Cartilage inj. n (%) 10 (29) 4 (11) n.s. 
Transtibial technique n (%) 12 (35) 10 (29) n.s. 
Anteromedial 
technique 
n (%) 22 (65) 25 (71) n.s. 
Patient demographics at baseline for patients who underwent ACLR are displayed as mean ± SD, 
number and percentage, respectively. Statistical significant (p < 0.05) values were only seen for the 
time from injury to reconstruction. 
 
4.1.1 Study I 
In the study, 70 patients were included and randomised, and one dropped out due to waiting 
time. Therefore, 69 patients were analysed at six months. As seen in Tables 2–3, no 
differences were found between the groups except the time from injury to reconstruction. The 









4.1.2 Study II 
In Study II, the same study population as in Study I was assessed to compare total number of 
sick-leave days taken the first year following an ACL rupture in those undergoing acute and 
delayed reconstruction. The CONSORT flowchart is shown in Figure 2. No patients were lost 
in this follow-up. Eight patients in the acute group and 12 in the delayed group did not 
receive sick-leave and were therefore excluded. In regard to type of labour, there were no 
differences between the groups; see Table 4. 
Table 4: Occupation for study participants 









Working  49 (71)  26 (76)  23 (66)  n.s. 
Heavy 
manual labor 
12 (24)  8 (31)  4 (17)  n.s. 
Light  
manual labor 
20 (41)  10 (38)  10 (43)  n.s. 
Office work  17 (35)  8 (31)  9 (39)  n.s. 
No compensation  3 (4)  1(3)   2 (6)  n.s. 










4.1.3 Study III 
In Study III, the same study population as in Study I and Study II was assessed to look at and 
compare outcomes when assessed at a minimum of 24 months post-surgery. Twelve (17%) 
patients were lost to follow-up with no significant difference between groups (6 vs 6). There 
was no difference in mean follow-up time between the groups. 




4.2 STUDY IV 
Between 2013 and 2017, an orthopaedic team screened all patients presenting with an 
isolated ACL injury at the orthopaedic outpatient clinic. If they met the inclusion criteria, 
they were asked to participate in a one-centre RCT. In total, 504 patients were assessed for 
eligibility, and 140 patients were included. The inclusion criteria were a primary ACL injury 
in a knee-healthy person between 18 and 50 years of age with no additional injuries on MRI 
indicating a need for an acute procedure. The patients were randomised between IL and CL 
four-stranded ST autograft. The primary endpoint was isometric hamstring strength at six 
months. The patients were followed up at 6, 12 and 24 months; patients lost to follow-up are 
specified in the CONSORT diagram in Figure 4. The descriptives and demographic data of 
the study population were obtained at baseline and included patient age, gender, time from 
injury to surgery and concomitant injuries. They are presented in Table 5 with no significant 
differences. 








Age at inclusion, mean 
± SD 
33.1 ± 9 33.0± 9 31.1± 9 n.s. 
Gender: female, n (%) 58 (42) 33 (48) 25(38) n.s. 
BMI mean ± SD 25.1± 3,4 25.2± 3,6 24.9± 2,9 n.s. 
Time injury-recon  
median months (range)  
 5.8(1-188) 5.1(0.7-250) n.s. 
ST/G n(%) 8 (6) 4(6) 4(6) n.s. 
Additional injury n (%) 82(60) 41(60) 41(60) n.s. 
Medial meniscus n (%) 57(40) 29(42) 28(40) n.s. 
Lateral meniscus n (%) 31(22) 19(28) 12(17) n.s. 
Sutures n (%) 36(26) 16(24) 20(29) n.s. 
Cartilage inj n (%) 21(15) 7(10) 14(20) n.s. 
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ACL=anterior cruciate ligament Reconstruction CL=uninjured contralateral limb 
Patient demographics at baseline for patients with an ACL tear are displayed as mean ± SD, 
number and percentage, respectively. 






5.1 STUDY DESIGN 
5.1.1 Randomised Controlled Trial (RCT) 
RCTs are thought to represent the highest quality of evidence186. The key aspect of any RCT 
is the use of a control group, to which the experimental group is compared, and 
randomisation, which means that the participants are randomly assigned to the interventions. 
Randomisation ensures that the participants in each group have a similar distribution of 
characteristics to ensure that the groups are comparable in terms of known and unknown 
confounders.  
To reduce the risk of a RCT being underpowered, both the sample size and the power of the 
study need to be considered. A power analysis gives the researcher a way to establish the 
sample size required to study the expected difference between the groups. If the expected 
differences are small, a large sample size is needed to find the difference. If a study is 
underpowered, there is a risk of a type-II error, therefore failing to reject a false null-
hypothesis.  
Even though RCTs are considered the most accepted study design, this does not mean that 
they can ensure external validity. External validity refers to how the results can be 
generalised to other populations. An RCT often consists of homogenous populations and 
usually recruited with strict criteria, which make studies less applicable to other populations. 
5.2 SURGICAL TECHNIQUE 
5.2.1 Studies I–III 
The same surgical techniques were used for the ACLRs in Studies I–III. All patients 
underwent arthroscopic ACLR by four experienced surgeons. Additional injuries to the 
menisci were assessed and treated with resection, reinsertion with meniscus sutures or 
expectancy. The ST was harvested through an incision over pes anserinus, and a minimum 
length of 26 cm for the ST tendon was required to perform a four-strand ST-only 
reconstruction with a free periostal flap attached. If not sufficient in diameter, the gracilis 
tendon was harvested as well. The technique used for the first 22 patients in these studies was 
a TT approach, while the remaining 47 used an AM approach. This change was made due to 
the evolution of the surgical technique at the time. When using the TT approach, the tibia was 
drilled first, and then the femur was drilled with a TT drilling technique with an angle of 45°. 
With the knee in 80–90° of flexion, the surgeon aimed for a femur entry point at 10 or 2 
o’clock on the lateral wall using an offset guide of 5–7 mm. Using the AM approach, the 
surgeon drilled the femoral tunnel using an accessory medial portal, aiming for the centre of 
the femoral footprint. On the femoral side, the graft was attached with Endobutton 
Continuous Loop® (Smith & Nephew, Inc., Andover, MA 01810, USA). The cyclic 
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loading of the graft was done with 20 repetitions of full ROM before tibial fixation, which 
was performed with a metal interference screw, RCI® (Smith & Nephew, Inc., Andover, 
MA 01810, USA), or Soft Screw® (Arthrex Inc., Naples, Florida 34108, USA) in 90° of 
flexion. The distal fixation was also reinforced with osteosutures.  
5.2.2 Study IV 
The surgical technique for the ACLR in Study IV was the same for the two groups except for 
the harvesting site. Two experienced surgeons performed the reconstructions. Firstly, a 
diagnostic arthroscopy was performed. The ST tendon was then harvested through an AM 
longitudinal incision, and only if the ST tendon was not sufficient in length of 26 cm or 
diameter of 8 mm, the gracilis tendon was harvested as well. A free periostal flap was 
extracted from the same incision. The ST tendon was quadruple over two adjustable loops 
with a free periostal flap attached. On the femoral side, the surgeons used a Tightrope RT™ 
(Arthrex, Inc., Naples, FL) and for the tibial side Tightrope ABS™ (Arthrex, Inc., Naples, 
FL); the graft construct was secured with sutures of nr. 2 FibreWire™ (Arthrex, Inc., Naples, 
FL). The femoral tunnel was drilled using an accessory AM portal, and the ACL insertion site 
was marked with an awl aimed at the centre of the ACL insertion site in order to place the 
centre of the tunnel just behind the bifurcate ridge about 8–10 mm from the posterior 
cartilage with the knee in 90° of flexion. On the tibial side, the centre of the tunnel was placed 
in alignment with the anterior horn of the lateral meniscus. For the tibial cortical fixation, a 
‘TightropeButton’™ (Arthrex, Inc., Naples, FL) was used. The tensioning of the construct 
was performed by tightening the loops according to surgeon preference. 
5.3 REHABILITATION 
5.3.1 Studies I–III 
All patients used the same rehabilitation protocol and were treated at one physiotherapy 
centre to ensure all patients got the same postoperative treatment. Full weight bearing and 
ROM were permitted immediately as well as closed kinetic chain exercises. Open chain 
exercises were allowed after six weeks and running after 14 weeks. The patients were 
allowed to resume sport activity after Biodex® testing showed 90% strength in the injured 
leg compared to the CL leg but never earlier than six months. If the meniscus was sutured, the 
patient wore a brace for six weeks with limited ROM; otherwise, the rehabilitation was the 
same. 
5.3.2  Study IV 
The same guidelines were used for all patients as in Study I-III, but the patients chose where 
to do their physiotherapy by themselves. The patients were permitted immediate full weight-
bearing and full ROM. If the meniscus required suturing, the knee was fixed in a brace with 
limited ROM for six months, 0–60° for four weeks and 0–90° for another two weeks.   
Closed kinetic chain exercises were started immediately postoperatively. Open chain 
exercises were allowed after six weeks, running was permitted at three months and contact 
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sports at nine months at the earliest, provided that the patient had regained full functional 
stability and Biodex® testing showed 90% strength in the injured leg compared to the CL leg.  
5.4 CLINICAL EXAMINATIONS 
Range of motion (ROM) 
The patients were examined using a goniometer along the scale 0–180°. The uninjured leg 
was used as a reference and evaluated first. The maximum range of active ROM was 
measured, and the examiners also noted any cases of hyperextension.  
The Lachman test 
The Lachman test, with reported sensitivity values ranging from 0.63–0.93 and specificity 
values ranging from 0.55–0.9938, is performed with the patient’s knee in 30° of flexion and is 
assessed relative to the CL knee. The tibia is pulled forward to assess the amount of anterior 
translation of the tibia. An intact ACL should prevent forward translational movement, while 
an ACL injury will demonstrate increased anterior translation without an endpoint. A 
difference between the legs of more than 2 mm indicates an ACL injury39 40. To quantify the 
anteroposterior laxity, the most common devices are the KT-1000 and the Rolimeter; both 
can be used to determine the movement in millimetres41 42. The studies use the grade normal 
or not. 
The pivot shift test 
The pivot-shift test is performed by applying valgus stress and axial load while internally 
rotating the tibia as the knee is slowly moved from extension to flexion. This test is 
considered positive if the proximal tibia subluxates anteriorly on the distal femur at about 30° 
of flexion44. The test has a sensitivity of 0.18–0.48 and a specificity of 0.97–0.9938. However, 
the grading of the pivot shift test is highly subjective, therefore impossible to compare 
grading between studies45 46. In these studies, the pivot shift was either graded normal or not.  
5.5 INSTRUMENTED LAXITY 
Rolimeter® 
Rolimeter® is a validated instrument that quantifies anterioposterior knee laxity41 42. The 
Rolimeter® is used by fixating to the patient’s leg with a single adjustable ankle strap distally. 
There is a curved proximal plate that should be placed on the centre of the patella. The 
examiner then puts one hand on this to stabilise the patella and in turn fixate the femur. A 
metal stylus is then placed on the patient’s tibial tuberosity. A modified Lachman test is then 
performed as the examiner applies full manual force. The anterior displacement of the stylus 
can then be read directly with no possibility for failure of calibration or machine error. It has 




5.6 FUNCTIONAL TESTS 
One-leg hop test 
This is a reliable multifunctional assessment for evaluating joint mobility, muscle strength, 
coordination and timing. To conduct the test, the patient stands on one leg and is asked to 
jump as far as possible and still be able to stick the landing on the same leg. The distance is 
then calculated in relation to the healthy limb and an index of more than 85% has been used 
as a limit for patients to be regarded rehabilitated after ACLR188-190.  
Strength using the Biodex dynamometer 
A dynamometer provides an objective measurement of muscle strength; although it can be 
criticised for lacking functional relevance to sport and training, it is still regarded as the 
‘golden standard’. There are several different on the market. In the studies conducted, the 
Biodex (Biodex Medical Systems, Shirley, NY, USA) is used. The Biodex dynamometer 
(Biodex Medical Systems, Shirley, NY, USA) is a validated instrument191. It can be used in a 
number of angular velocities for measuring isokinetic torque and a number of fixed angles for 
measuring isometric torque. Usually, the test person does three repetitions, and the values are 
then averaged in the system. When performing the Biodex test, the patient sits in an upright 
chair with his/her leg strapped to a movable part of the testing machine. The patient is 
instructed to fully straighten and then fully bend the knee for multiple repetitions. The test 
results are used to objectively compare the surgical to the non-surgical side as well as to 
compare the quadriceps and hamstring muscles in the same leg. One limitation is that the 
patient is in a sitting position, which restricts the flexion from going further than 100°. This 
makes it impossible to assess strength in deep flexion.  
5.7 FUNCTIONAL SCORES 
The International Knee Documentation Committee (IKDC) classification 
The IKDC developed an evaluation form to classify the knee after an injury. The standard 
form consists of the following eight problems: the patient’s subjective assessment, symptoms, 
ROM, ligament examination, compartment findings, donor site pathology, radiological 
findings and functional tests. The first four groups are used for the final overall IKDC rating, 
and every point is rated A–D (normal to severely abnormal)125.  
IKDC subjective knee form score (IKDC 2000) 
Developed in 2001, it is a subjective knee evaluation form, revised from the original IKDC 
form, regarding function, symptoms and sports activity. It contains 11 questions and a total 
score range from 0 to 100, with higher scores indicating better results. It is validated, but the 
IKDC2000 has not been shown to be reliable for the longitudinal evaluation of function at 





This instrument focuses mainly on symptoms and complaints but not functions in sport and 
recreational activities. The scale consists of eight items with a total maximum score of 100. 
The eight functions are limp (with maximum 5 points), support (5 points), locking (15 
points), instability (25 points), pain (25 points), swelling (10 points), stair climbing (10 
points) and squatting (5 points). A result of less than 65 is often regarded as poor, 65–83 as 
fair, 84–94 as good and 95–100 as excellent193-195. 
Tegner activity level 
The Tegner activity level is used for grading sport and work activities on a scale from 0 to 10 
and is meant to be used together with the Lysholm score as a complement195.  
VAS 1 and VAS 2  
These questions were used to rate the patients knee function on a visual analogue scale 
ranging from 0–100, with 0 being the worst possible score and 100 the best possible score. 
VAS 1 was the question ‘How does your knee function?’ and VAS 2 ‘How does your knee 
function affect your activity level?’  
5.8 HEALTH-RELATED QUALITY OF LIFE (HRQOL) EVALUTAION 
Knee Injury and Osteoarthritis Outcome Score (KOOS) 
The KOOS is a valid, knee-specific widely used self-administered questionnaire. It is used as 
an outcome measure in the SKLR21 and can be used to measure change over time126 127. It 
contains 42 questions in five subscales of pain (9 items), other symptoms (7 items), activities 
in daily living (ADL) (17 items), function in sport and recreation (5 items) and knee-related 
quality of life (QoL) (4 items). All questions are graded from 0 to 4 points. A normalised 
score for each subscale is then calculated, with scores range from 0 to 100, with higher score 
indicating better results. Barenius et al.128 defined based on a Swedish population both FR 
and TF. For FR, all subscales had to be above 90 for pain, 84 for symptoms, 91 for ADL, 80 
for sp/rec and 81 for QoL, and TF was defined as a score below 44 on QoL. 
5.9 STATISTICAL METHODS 
The data in all studies were analysed using SPSS version 22 or 25 (IBM, Armonk, NY, USA) 
for Macintosh.  
Mean and SD or median and range were calculated for descriptive statistics depending on the 
normality of the data. Statistical significance was defined as p < 0.05 for all analyses and was 
two-sided in all studies. To compare between groups, the Student’s t-test (quantitative, 
normally distributed data), Mann-Whitney U-test (ordinal data or non-normal distributions), 
chi-squared test and Fisher’s exact test (nominal data) were used as appropriate.  
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Power analyses were conducted for Studies I, III and IV to estimate enough number of 
patients to include in the different studies. In Studies I and III, the sample size calculation was 
based on the primary outcome variable ROM at three months post-surgery, and the number of 
interest was 5° loss of extension according to a previous study. From clinical experience the 
normal range at three months is 110–135°, which stipulates a mean of 122.5. The 
computation assumes that the mean difference is 5 (corresponding to means of 122.5 vs 
117.5), and the common within-group standard deviation is 7.0. The sample size required was 
64 patients, 32 patients in each group calculated with use of a study power of 80% and a type-
1 error (α) of 0.05. 
In Study IV, the primary endpoint was isometric hamstring strength at six months. To detect a 
difference of 10% (SD ± 15) with a study power of 80% and a type-1 error (α) of 0.05, the 
study would need at least 37 patients in each group. 
In Study II, a post hoc power analysis using G*Power 3.1.9.2 (Franz Paul, Kiel, Germany) 
was used to determine the effect size and power of the study. Based on the results at one year 
in the study population, an effect size of 0.73 was calculated, with α set at 0.05 and a two-
sided test, the power of the study was calculated to 71%. 
5.10 ETHICS 
When performing any type of research, especially when testing new methods, the researcher 
must value the potential benefits against the harm one could cause to the patients. Before 
research is conducted, approval from an ethical committee is required. The regional Ethical 
Review Board in Stockholm has evaluated and approved all studies in this thesis (Dnr I-III 
2006/404-31/3/2008/1541-32; Dnr IV 2013/1398-31/2) and was conducted according to the 
Declaration of Helsinki. This states, for example, that participation is voluntary and that the 
study participants can withdraw from participation at any time. Prior to study participation, 
the participants are provided with information about the study both orally and in writing, and 
written informed consent is obtained. To protect the integrity of the participants, each patient 





6 SUMMARY OF PAPERS 
6.1 STUDY I 
6.1.1 Introduction 
Historically, acute ACLR has been avoided due to reports of early rehabilitation problems 
with stiffness. The aim of the RCT was to assess the impact of the time between injury and 
reconstruction on the ROM after ACL surgery. The hypothesis was that with modern 
techniques it is safe and can be beneficial to reconstruct the ACL in the acute phase.  
6.1.2 Material and methods 
During the period 2006–2013, 70 patients with a high recreational activity level, a Tegner 
level of six or more, were randomised to receive ACL reconstruction with a four-strand ST 
graft within eight days of injury or after normalised ROM 6–10 weeks after injury. For 
fixation, an Endobutton® in the femur and a metallic interference screw in the tibia were 
used. The rehabilitation training was performed at the same physiotherapy centre for all 
patients. A power analysis indicated a need of 64 patients to find a 5° difference in ROM at 
three months. For the first three months, the patients were followed weekly by SMS with the 
question ‘How is your knee working?’ ROM was assessed after three months as the primary 
outcome. The follow-up at six months included a Biodex strength test, Lachman, Rolimeter, 
pivot shift, one leg hop, IKDC, KOOS, Lysholm and Tegner activity level. 
6.1.3 Results 
Seventy percent of the patients were males, the mean age at the time of inclusion was 27 
years (18–41) and the pre-injury Tegner level was median 9 (5–10), with no differences 
between the groups. One patient in the delayed group dropped out before surgery. In total, 64 
patients (91%) were assessed at three months. 
At the three-month follow-up, the patients were assessed for the primary variable, with no 
significant differences in any range of motion demonstrated between the groups.  
At the six-month follow-up, the delayed group had significantly more muscle atrophy of the 
quadriceps compared to the CL leg. Furthermore, significantly higher proportions of patients 
in the acute group passed the one leg hop test (47 vs 21%, p < 0.05). Additionally, no 
significant differences between the groups were found in the other clinical assessments nor in 
terms of associated injuries.  
6.1.4 Conclusion 
Acute ACLR can be performed safely without an increased risk of developing stiffness. 
There are potential benefits as patients who underwent acute surgery had less muscle 
hypotrophy in the early phase of the rehabilitation process.  
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6.2 STUDY II 
6.2.1 Introduction 
As an ACL injury is a functionally disabling injury and often prevents patients from returning 
to work from the time of the injury to the time of reconstruction, acute ACLR may facilitate 
an earlier return to work. Measuring sick-leave days for the first year after an ACL injury is 
an easy way to measure socioeconomic costs. It was hypothesised that an acute ACLR results 
in fewer sick-leave days without inferior PROs.  
6.2.2 Material and methods 
The same study population as in Study I was used. Data from the Swedish Social Insurance 
Agency, Försäkringskassan, were obtained for information about the number of sick-leave 
days due to the knee injury and over the following 12 months and compared between the two 
groups. Only sick-leave days based on a diagnosis of ACL injury were included in the study. 
The follow-up at 12 months also included a Biodex strength test, Lachman, Rolimeter, pivot 
shift, one leg hop, IKDC, KOOS, Lysholm and Tegner activity level. 
6.2.3 Results 
All patients were assessed regarding the number of sick-leave days. Three patients (4%) did 
not claim sick-leave compensation due to self-employment, and another 17 (25%) were 
students and therefore not eligible for sick-leave compensation. The remaining 49 (71%) 
were distributed by 26 in the acute group and 23 in the delayed group, accordingly. There 
were no differences between the groups regarding line of work. The mean number of sick-
leave days for the acute group was significantly lower (M=57, SD=36) compared to the 
delayed group (M=89, SD=50; p < 0.05), Figure 5. The delayed group also had a different 
distribution of the days – one continuous or two separate periods, depending on type of work. 
There were no significant differences between the groups in any other assessment.  
6.2.4 Conclusion 
On an individual level, acute ACLR resulted in fewer sick-leave days. From a societal 
viewpoint, there is a potential economic benefit in identifying individuals who would benefit 
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6.3 STUDY III 
6.3.1 Introduction 
ACL tears are common injuries, and ACL reconstructions, regardless of the technique and 
graft source, are considered safe and effective procedures. Injury-to-surgery time still remains 
controversial. There have been recommendations to delay ACLR due to the risk of AF even 
though several studies have shown acute ACLR to be a safe option. In an initial study with 
the primary endpoint of ROM at three months showed no significant differences regarding 
ROM or clinical outcome at six months. The aim of this study was to assess two groups 
randomised to acute ACLR within eight days or after 6–10 weeks when ROM was 
normalised at a minimum of 24 months post-surgery. It was hypothesised that an acute 
ACLR would not result in inferior PROs nor a higher frequency of ROM deficits.  
6.3.2 Material and methods 
The same study population as in Study I was used. The follow-up at six months included a 
Biodex strength test, Lachman, Rolimeter, pivot shift, one leg hop, IKDC, KOOS, Lysholm 
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meniscal repair failures requiring revision meniscus surgeries were recorded during the trial 
period.  
6.3.3 Results 
Twelve (17%) patients were lost to follow-up, with no significant difference between groups 
(6 vs 6). Early extension deficit seen at three months had resolved. The patients in the acute 
group perceived their knee function as better than those in the delayed group (VAS 1 & 2, 
p=0.016 and p=0.022, respectively), and the median Tegner level was restored to pre-injury 
and desired levels for both groups. KOOS showed a significant improvement in all subscales 
from the preoperative status, Figure 6, and the FR rate was near 40%, which is almost double 
that in the SKLR, with no differences between the two groups. Also, TF was reduced to half 
of that in SKLR. There was no increased risk for additional surgery whether the 
reconstruction was performed acute or delayed. 
6.3.4 Conclusion 
The study provides further evidence that acute ACL reconstruction can be performed safely 
without an increased risk of developing stiffness.  
Figure 6: Mean KOOS scores 
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6.4 STUDY IV 
6.4.1 Introduction 
When performing ACLR, the surgeon usually uses an autograft from the same, IL, leg. 
Taking the graft from the uninjured, CL, leg would theoretically mean that the injured leg 
does not need to suffer any additional damage in connection with ACLR. There are a few 
studies using BTPB from the CL leg for primary ACLR and numerous on revisions with 
good results. There are only two studies that have been published using a hamstring graft, and 
in both cases the studies used an STG graft. Using only the ST does not compromise strength 
and function as much as harvesting both tendons. The aim of the RCT was to assess the 
impact of ST graft harvest from the CL leg compared to the IL leg when performing ACLR. 
The hypothesis was that using a CL ST graft is safe and can be beneficial regarding strength 
recovery as the knee does not take on a double hit. 
6.4.2 Material and methods 
Between 2013 and 2017, 140 patients were randomised to receive ACL reconstruction with a 
four-strand ST graft harvested from either the IL or the CL leg. Two surgeons performed all 
ACL reconstructions with the same technique. The graft fixation on the femoral side was 
done using an adjustable loop Tightrope™. The fixation on the tibial side was done using a 
Tightrope ABS. The rehabilitation was standardised but free of choice for the patient. A 
power analysis indicated a need of 74 patients to find a mean 10% difference in isometric 
hamstring strength at six months. A Biodex strength test was performed at six months as the 
primary outcome. The follow-up at six, 12 and 24 months included a Biodex strength test, 
Lachman, Rolimeter, pivot shift, one leg hop, IKDC, KOOS, Lysholm and Tegner activity 
level. 
6.4.3 Results 
A total of 140 patients were initially included in the study. For the primary outcome at six 
months, 38 patients were lost to follow-up, and for final analysis, an additional seven patients 
were lost, which left 95 patients (46 in the IL group and 49 in CL group). Both groups were 
comparable in terms of demographic details and preoperative scores and findings. 
At the six-month follow-up, the patients were assessed for the primary variable, with the CL 
group significantly stronger in isometric hamstring strength and continuing to be so at 12 
months as well. However, at 24 months, no difference in isometric strength could be seen, 
Figure 7. Regarding isokinetic flexion muscle strength and total work in flexion, the IL group 
was significantly weaker in all velocities during the trial period, Figure 8 and 9. No 
differences were found between the groups in the other clinical assessments. 
The mean Lysholm, Tegner and IKDC scores at all time points after surgery were 
significantly improved as compared with mean preoperative scores in both the groups with no 
difference between them. FR rate was in line with the SKLR. Failure of ACLR was observed 
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in two patients in each group. All cases of failure were due to significant re-injuries. One case 
of CL ACL injury was found in the CL group.  
6.4.4 Conclusion 
CL graft harvest is a safe option with potential benefits and no measurable disadvantages. 
The CL group showed early symmetrical strength between the limbs, while the IL group 
stayed asymmetrical during the whole trial.  
Figure 7.  
The average isometric extension muscle strength after surgery displayed as mean percentage 
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7 STRENGTH AND LIMITATION 
In general, there is a limitation in this thesis that the first three studies are quite similar as they 
assess the same study population. 
As for strength testing, there are many factors that may influence the results. The test subjects 
are influenced by their experience of the situation and psychological aspects surrounding the 
testing situation. There are variances between results, and there is a need of enough subjects 
to have reliable results. For these reasons, the strength testing in Studies I–III should be 
interpreted with some caution. In Study IV, however, there should be enough subjects 
according to the power calculation made.  
Regarding all the studies, they are only what one could describe as short-term follow-ups 
although two years has been described as a minimum follow-up time period196. For the 
follow-up period in Study I, it was clearly defined in the study aims that the primary endpoint 
was ROM at three months. The follow-up for 24 months in Study III instead answered other 
important questions, such as reruptures, revisions and activity level.   
7.1 STUDY I AND III 
The strengths of the studies were the prospective, randomised design and that the patients in 
the groups were comparable in terms of age, gender and pre-injury Tegner activity level. 
Further, the patients were reconstructed using the same type of graft and had the same 
supervised rehabilitation programme.  
Potential limitations are the limited number of patients; though there were sufficient numbers 
according to the power analysis, there is still a possibility for a type 1 error to occur. Another 
limitation is the change in surgical method (TT vs AM portal drilling). The studies also offer 
only short-term results, as mentioned above. Another limitation is that the study population is 
very specific, and one could argue that the results are due to the specific type of subjects in 
the study and making it hard to generalise the results to all patients with an ACL injury. The 
knee outcome scores in Study I should also be interpreted carefully as at least a one-year 
follow-up is required to obtain meaningful measures197. 
7.2 STUDY II 
The main limitation is that the power analysis was performed to detect loss of ROM and not 
sick-leave days. The post hoc analysis did, however, show a high effect size, which supports 
the likelihood of the results being true. Sick-leave days are a blunt measure for 
socioeconomic costs as there are several other factors that affect the total cost of ACLR. We 
did not have a non-operative counterpart for comparison, and our study focused only on 
individuals with at least a moderate activity level, thus making it hard to generalise. 
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7.3 STUDY IV 
 The major strength of this study is that it is a randomised trial with only two experienced 
orthopaedic surgeons performing ACLR with the same standardised technique. The groups 
were comparable in terms of age, gender and additional injuries, and both subjective and 
objective measurements were made. The study population is also easy to generalise as the 
inclusion criteria are not as slim as those in the other studies. 
One limitation of the study is that the rehabilitation was not supervised, so it cannot be 
determined whether all patients got the same rehabilitation. Another weakness of the study is 
the loss of follow-up. A big loss of follow-ups was anticipated, and the number of 
participants in the study were included accordingly. There is a common opinion that a 
dropout rate of more than 20% is a threat to the validity and the power of a study196. In this 
case, the dropout rate was 33% for the final analysis although enough subjects were analysed 
according to the present power analysis. In a comparison with the characteristics of those who 
completed the study versus those who did not, there were no differences. Another limitation 
is that we did not use a ‘battery of tests’ that have been suggested to better assess functional 
assessments and to discriminate between the injured and non-injured leg, instead used only 
one hop test198. Another potential limitation is that the possible reduction in the strength of 
the CL leg when harvesting the HT will inflate the symmetrical index, thereby leading to a 
misrepresentation of the functional ability of the injured limb. As described, there are only 
short-term follow-ups for 24 months. However, the study includes clinical examinations, 




The overarching aim of this doctoral thesis was to develop a better understanding as to 
whether we can improve subjective and objective outcomes after ACLR with different 
strategies and mind sets, and the focal point has been on the patient’s perspective. To achieve 
this, the doctoral thesis is based on four studies, all of them RCTs.  
Even though the ACL injury is one of the most studied in the field of orthopaedics, there is 
still debate regarding everything from timing to graft choice and even whether surgery is 
necessary. What is certain is that the main goal for all treatment is a stable knee joint with as 
little morbidity as possible.  
8.1 TIMING OF ACLR 
As previously stated, the ideal timing for ACLR has not been identified and is still under 
debate. In Studies I–III, ‘acute’ or ‘early’ was defined within eight days after the injury and 
‘delayed’ after 6–10 weeks. The most important findings in the Studies I–III were that at the 
three-month follow-up, no significant differences in ROM between groups were evident and 
that at six months postoperatively, the ‘delayed’ group had more muscular hypotrophy of the 
quadriceps. Additionally, at 12 and 24 months, PROs were similar. There is, however, no 
clear and accepted definition in the literature as to what should be regarded as early and 
delayed ACLR. There has been opposing evidence on the risks and benefits of early 
reconstruction, in which early surgery was classified as ranging from within two days to 
seven months and delayed surgery as ranging from three weeks to 24 years after the injury109 
199. In more recent meta-analyses surgery within three weeks has been defined as early, 
avoiding overlaps between the groups, and these studies could report good final outcomes 
without a higher risk of complications, in line with the studies in these thesis111 122 123.  
The average time between injury and reconstruction in the SKLR is between 400 and 500 
days (13–17 months)200, and there are also differences between countries1. The majority of 
ACLRs were performed within six months in the UK and the US and after six months in the 
Scandinavian countries. There might be several reasons for this. One reason could be that 
Sweden has embraced a treatment algorithm where most patients first receive non-surgical 
treatment to explore whether they are copers, thereby extending the time to surgery. This is in 
line with both the traditional dogma that surgery should be delayed for at least six weeks to 
decrease swelling and regain ROM as well as adequate time for decision-making and to 
prepare the patients both mentally and physically, as not every patient needs surgery106 201. 
The risk for AF has been one of the main reasons to delay treatment106 161, but Studies I–III 
did not find an increase in AF. This is in line with other more recently published high-level 
trials122 123. The studies that advocated delayed surgery due to AF were all done during the 
1990s, with different rehabilitation, arthrotomy techniques and nonanatomic graft 
positioning106 161. The evolution of rehabilitation and surgical techniques has made it safer to 
perform early ACLR. AF following ACLR is a major complication, but another aspect is 
what should be classified as AF. In Studies I–III, the primary outcome was ROM at three 
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months, and the power calculation was made from a definition of AF as 5° loss of extension 
from a study by Shelbourne et al.159. It was not until recently that a more modern 
classification was made, and it can be hard to evaluate other studies in regard to what really 
should be classified as AF160. Another reason is logistics and waiting lists, the latter due to 
lack of resources. 
The decision to reconstruct the ACL should be individualised. Not all patients need ACLR 
even if it has traditionally been recommended for young, healthy patients with the desire to 
engage in pivoting sports. Frobell et al. conducted a prospective randomised trial comparing 
early ACLR (i.e. within 10 weeks) with optional delayed reconstruction (both with the 
inclusion of structured rehabilitation) and reported no significant differences between the 
groups according to KOOS, Tegner activity level or meniscal tears requiring surgery or OA 
findings at two and five years6 47. However, patients that required meniscal fixation were 
excluded, and half of the patients in the optional delayed group opted for reconstruction 
during the trial. In addition, the non-operative group showed greater knee laxity as well as 
more meniscal injuries (13 vs 1). 
Delaying ACLR might increase the risk for more damage to the knee. Studies I–III did not 
find any differences between the groups regarding additional injuries, but the literature 
reports evidence of increased risk of damage over time. Granan et al. found an increased risk 
of meniscal tears for every month passed25. Other studies have also reported significantly 
more meniscal and cartilage injuries when delaying surgery54 202 203. In contrast, a recent 
systematic review by Ekås et al. could not find evidence that surgery decreases the risk for a 
new meniscal tear204. Further, the presence of meniscal or cartilage injuries in combination 
with an ACL tear contributes to the development of OA4 205. ACL injuries are associated with 
a higher risk for OA regardless treatment206. However, when a meniscal injury was present, 
the prevalence of OA increased between 21–48%, further highlighting the importance of not 
sustaining further injuries205. There are also data suggesting that ACLR can to some degree 
prevent OA development177 206. None of the studies in the thesis have long-term results, but 
saving the meniscus and keeping the kinematic might save the knee further and in the long 
term reduce the risk for OA. 
Due to the Swedish healthcare system, an acute reconstruction within one week of injury is 
not always possible, but most patients can be evaluated within the first week after the injury. 
Non-operative treatment of an ACL injury can be discussed in less active patients and then 
the need for surgery can be re-evaluated within a reasonable timeframe so that the patient, if 
not a ‘coper’, can be reconstructed before additional injuries to the knee are sustained. 
However, not offering a young and active athlete patient an early ACLR is not an acceptable 
option. Of course, there is a risk of overtreatment, but in the best case scenario, the surgery 
will save the menisci from further damage. If a decision for ACLR has been made, there is no 




8.2 ACTIVITY LEVEL AND PROS 
In general, the outcome after ACLR is largely dependent on the secondary injuries the knee 
has sustained during the time from the injury to the reconstruction. But how do we measure 
outcome, and what can be regarded as success? There are of course the objective 
measurements, such as laxity, reruptures and concomitant injuries, but these do not take in to 
account how the patients feel. A successful treatment surely means different things to 
different people. For an elite athlete, success might be returning to sport participation as soon 
as possible, while to others success is defined as performing at the same level as before the 
injury. For the surgeon, an objective stabile knee can define success. PRO highlights the 
patient’s perception of the treatment. The two most commonly used PROs after an ACL 
injury are the KOOS and the IKDC-SKF, both which are validated126 207. Moreover, both 
have advantages and disadvantages. KOOS covers five subscales (pain, symptoms, ADL, 
sp/rec and QoL) but was originally developed for OA and its progression. It contains many 
questions, 42, several that might seem a bit ‘easy’ for the patient, and does not include 
specific items relating to instability. The IKDC form has fewer items to answer and was 
associated with more questions that the patients felt important in recognizing their 
difficulties after an ACL injury208. A comparison between IKDC and KOOS found the 
subscales sp/rec and QoL to be the most important to the patients209. However, the results 
can be difficult for the clinician to understand and interpret. A clinically meaningful change 
in PRO may not be associated with an acceptable state corresponding to ‘feeling well’. In 
Study III, the term functional recovery (FR) is used, a score defined by Barenius et al. as a 
KOOS value above the lower threshold for the 95% CI of 18–34-year-old males in a Swedish 
reference population for all subscales128. FR is equivalent to a return to a nearly pre-injury 
KOOS level, setting the bar high. In Study III, FR rate was almost 40% for both groups, and 
that is almost double of that in the SKLR128. Barenius et al. could not find that time between 
the injury and reconstruction was a negative predictor for FR, but the outcome was influenced 
by additional injuries, often sustained during the waiting period. This could explain why FR 
was so high in Study III as both groups were reconstructed before experiencing episodes of 
giving way and therefore did not sustain additional injuries to the already injured knee. 
Although not as glamorous, TF should be regarded as important as success. In Study III, a 
KOOS QoL subscale value of < 44 points was used as a cut-off for TF. This value originates 
from a study by Frobell et al. in which it was used as a criterion for crossover from non-
surgical to surgical treatment and was also used in the study by Barenius et al.47 128. In Study 
III, the TF rate was half of that of the SKLR, which further highlights the importance of 
avoiding additional injuries to the knee128. More recently, another study defined thresholds 
for PASS for each subscale of the KOOS and IKDC by asking the patients if the state of their 
knee was satisfactory, and several studies have since applied these values129 130 210. The 
thresholds for PASS are lower than that of FR and are therefore easier to pass. Ingelsrud 
conducted a similar study on defining TF, asking the patients if they thought their treatment 
had failed, and got a threshold of KOOS QoL subscale < 28131. If the threshold used by 
Ingelsrud and Muller was to be applied on the patients in Study III, 72% would reach the 
PASS criteria, no difference between the groups and only 5% TF – this in comparison with 
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the study by Cristiani, where 60% achieved PASS, and with Ingelsrud, where 13% failed130 
131. In Study IV, PASS was achieved for 57% within the KOOS subscales, which is in line 
with the previous studies, and TF 7%, which is better than the study from Ingelsrud130 131. The 
patient group in Study IV might not be young, high-level athletes struggling to get back to 
high-level sport but rather patients trying to cope with the potential limitations of their 
reconstructed ACL status.  
As the main goal after treatment of an ACL injury often is the RTS, a way to measure 
outcome is to look at the activity level and to what extent patients RTS. While an objective 
good knee function is important for the RTS, there are other psychological factors to consider 
as well. The Tegner activity score does grade the activity level but not activity exposure, and 
thus, although patients may have reached a similar Tegner level, they may have never 
returned to the same level of play as before the injury195. In all studies, there was a 
distinguishable difference between pre-injury and pre-surgery activity level. In Study III, the 
median Tegner activity level was restored for both groups, and more than 93% of the patients 
had returned to recreational sports within two years. In Study IV, the activity level had 
decreased at the two-year follow-up from a median of 7 and 8, respectively, to 5 for both 
groups. This is in line with a meta-analysis by Ardern et al. in which only 55% returned to a 
competitive sport and 63% to their pre-injury Tegner level even though almost 90% had a 
nearly normal IKDC143 211. Another aspect and difference between the two study populations 
in Studies III and IV is that in Study III the patients were younger, composed of more men and 
had a higher pre-injury Tegner level, all of which are important factors for RTS after an ACL 
injury211-214. Another factor that influences the RTS is concomitant injuries215. In Study IV, 
there were more treatments for meniscus, another reason for not delaying ACLR.  
8.3 MUSCLE FUNCTION 
Strong muscles around the knee protect the joint and are a key factor in the rehabilitation after 
ACLR in order to RTS. There is no clear consensus to determine when patients can RTS after 
ACLR, but time after surgery, stability and symmetrical muscle strength have been reported 
as key factors198 216 217. A recent study showed that for every month RTS was delayed from 
six up to nine months postoperatively, the re-injury incidence was reduced by 51%140. 
Symmetry between the injured and uninjured legs, often referred to as the limb symmetry 
index (LSI), has been defined as ≥ 90% of muscle function, and this cut-off has been reported 
to decrease the risk of another ACL injury after RTS140 198. Using an autograft impairs either 
the knee extensor or flexor mechanism, depending on graft218. The HT graft preserves 
quadriceps function but weakness of the hamstring has been reported with inferior knee 
function after ACLR219 220. The HT also has a stabilising effect in valgus stress221. Studies 
also suggest that decreased hamstring strength in combination with higher quadriceps 
strength might be a factor for ACL rupture222 223. In Studies I–IV, strength measurements were 
performed using a Biodex System (Biodex Medical Systems, Shirley, New York, USA) and 
the one leg hop test. In Study I, the acute reconstruction group had less muscular hypotrophy 
of the thigh muscles, and a significantly higher proportion of patients passed the one leg hop 
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test. This might indicate that ACLR before extrinsic quadriceps inhibition might help 
preserve muscles and function. It would be of great value to compare the difference between 
early and delayed surgery in terms of recovery time from an ACL injury. 
In Study IV, using an ST graft from the CL leg resulted in improved flexion muscle strength 
and symmetrical strength between the limbs as early as six months post-surgery, while in the 
IL group the asymmetry remained after two years. Several other studies have reported 
asymmetry more than two years after surgery198 224 225. Avoiding a double hit to the already 
injured knee might lessen the burden to restore muscle strength. Muscle strength is a critical 
factor for the outcome after ACL reconstruction, and attaining symmetrical knee function 
should be considered a cardinal aim of rehabilitation due to the preventive effects of 
secondary injuries. 
8.4 ASPECTS OF ECONOMY 
As ACLR is one of the most commonly performed orthopaedic procedures, in Sweden alone 
about 4000 per year, there has been an interest in determining the value of the intervention by 
ACLR and developing value-based healthcare200. Mather et al. and Farshad et al. both used 
economic modelling to compare ACLR to non-operative treatment and found ACLR to be 
more cost-effective113 180 226. Stewart et al. compared competitive athletes in another cost-
effectiveness analysis, and the incremental cost-effectiveness ratio(ICER) of an ACLR in 
comparison to physical therapy was approximately $22,000 per QALY-year182. There are, 
though, limitations to these models as they do not measure any indirect costs, such as missed 
workdays and loss of productivity. Kiadaliri et al. conducted an analysis of the cost-
effectiveness of early versus optional delayed ACLR and could not show any economic 
benefits of early ACLR over a five-year period227. There are, however, some questions 
regarding the calculation of the number of sick-leave days, too, as 23 of 59 patients in the 
optional delayed group were dismissed in the calculation. Marcano et al. showed in a recently 
published study a trend that ACLR, especially earlier operative treatment, was associated 
with a more positive change in income compared with conservative treatment228. In Study II, 
a delayed ACLR resulted in significantly more sick-leave days (89 vs 57 days) within the first 
year compared with an acute ACLR, resulting in higher indirect costs. The result might be 
generalisable for countries with healthcare systems and guidelines similar to those of Sweden, 







9.1 STUDY I 
▪ Acute ACLR can be performed safely without an increased risk of developing 
stiffness within the first three months.  
▪ Patients who underwent acute surgery had less muscle hypotrophy of the thigh 
muscles in the early phase of the rehabilitation process. 
▪ This support that clinicians can make the optimal decision for each individual patient. 
9.2 STUDY II 
▪ Patients who underwent acute reconstruction required significantly less sick-leave 
compensation than those who underwent delayed reconstruction and had fewer 
indirect costs after ACLR. From a society viewpoint, there is a potential economic 
benefit to identifying individuals who would benefit from acute ACLR. 
▪ Acute and delayed ACL reconstruction provided comparable clinical outcomes after 
12 months with no significant differences. 
9.3 STUDY III 
▪ Acute ACL reconstruction can be performed safely without an increased risk of 
developing stiffness and other adverse effects. 
▪ Acute or early ACLR, which is performed before recurrent giving ways occur, 
increases the likelihood of achieving FR. 
▪ Rehabilitation should be focused postoperatively rather than preoperatively.  
9.4 STUDY IV 
▪ CL graft harvest is a safe option with potential benefits. 
▪ There are no measurable subjective or objective disadvantages. 
▪ The CL group showed early symmetrical strength between the limbs. 
▪ The IL group remained asymmetrical during the trial. 
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10 FUTURE PERSPECTIVE 
The incidences of ACL injuries have risen in recent years, and ACLR has become more of a 
standard procedure. Despite being one of the most studied injuries, there are still 
controversies in the field of ACL research. Moreover, due to the large number of 
publications, there can be confusion when interpreting the results.  
To start, research would gain a great deal from consensus. To achieve qualitative research, 
consensus should be reached as to which outcome assessments should be used to obtain valid, 
reliable measures that reflect both subjective and objective outcomes. This is important to be 
able to compare studies. Future studies should define AF more precisely as well as define 
what should be regarded as early ACLR.  
As every patient is unique, it is important to individualise ACL treatment. By doing so, we 
can hopefully improve the outcome and reduce negative consequences. However, 
individualised ACLR accounts not only for the anatomy but also for graft choice, timing and 
activity. The results in this thesis suggest that early surgery results in better outcome and that 
prevention of OA could be achieved with ACLR before giving way occurs. It would be 
interesting to see more well-designed studies of early reconstruction with an anatomical 
reconstruction and look at the long-term data to better understand the effect on the 
development of OA. 
As part of individualising the treatment after an ACL injury, non-reconstructed patients need 
to be addressed in the same manner as the reconstructed. These patients need to be studied 
across a range of outcomes to improve the understanding on who will benefit from each 
treatment. There is also a need of larger, non-biased RCTs comparing modern ACLR with 
conservative treatment. 
Another thrilling development is registry-based RCTs (R-RCTs). These are randomised trials 
that use a clinical registry for outcome reporting. R-RCTs make it possible to recruit a large 
number of unselected patients with great external validity at a low cost, which has been 
demonstrated in cardiology229. As the follow-up also relies on registries, the impact on 
regular healthcare is minimal. R-RCTs could be very valuable for comparing treatments 
already in use in clinical practice. If integrated into the SKLR, one could compare treatments 
that usually would need very large sample sizes, such as graft choice, timing and fixation 
method.  
Nordenvall et al. conducted a highly interesting study showing that socioeconomic status 
(SES) had an impact on treatment after an ACL injury230. The same research group 
performed another study using SES as an alternative outcome when evaluating symptomatic 
surgery228. It would be intriguing to develop this further and also address different 
socioeconomic factors in the same way. There are great possibilities to use national registers 
to answer difficult questions. In the study by Nordenvall, a higher SES increases the 
likelihood of undergoing operative treatment230. One reason could be that patients with a 
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lower SES do not have the possibility to afford sick leave. It would also be interesting to look 
at the differences of sick-leave days between reconstructed and non-reconstructed patients 
and whether there are any differences depending on social class or geography by cross-
referencing the registers. Another question that needs to be answered is whether ACLR 
allows for a sooner return to work in general.  
Other important aspects for further research regard activity and RTS after ACL treatment. 
The Panther symposium has done tremendous work in defining the different stages of the 
RTS continuum after an ACL injury, including emphasising the importance of a 
multidisciplinary approach217. The outcome measurements are still a bit blunt, and a better 
measurement should be validated. From the results in this thesis, CL ST graft harvest 
promotes earlier muscle symmetry, and it would be interesting to look at the donor site 
morbidity after harvest as well as to study whether the early symmetry might facilitate a 
faster and higher RTS rate in a more active study population.  
As discussed, PROs can illuminate differences in treatment outcomes. There are, however, 
very few studies that have evaluated the effect of patients’ expectations on PROs, and in the 
area of ACL surgery there are no studies to date that have successfully described the 
relationship between patient expectations and postoperative PROs. To define the effect of 
patient expectations on PROs after ACL treatment is a very important subject to research in 
order to improve the patient experience after treatment. Despite the fact that the Internet can 
provide incalculable information, it is not clear how much of the information the patients 
really understand. This is an area that is not researched and could provide important 
information about the discrepancy between the patient’s and doctor’s view and on the 
expectations from the treatment. 
Even though we have learned a great deal, we must be humble in regard to the fact that we do 
not have all the answers and that what we know not to be the truth might change in the future. 
Future research needs to focus on using classic high-level studies with modern methodology 




11 POPULAR SCIENCE SUMMARY 
An ACL injury is a serious knee injury that often affects younger individuals in connection 
with sports. The sports where the injury is most common are football, handball, floorball, 
alpine skiing and basketball. People who sustain an ACL injury are often forced to end a 
sports career prematurely. The injury can cause lifelong discomfort and often leads to early 
development of knee OA regardless of how it is treated. An ACL injury can either be treated 
surgically, when creating a new cruciate ligament using a piece of tendon from another part 
of the knee, or without surgery, when working through structured physiotherapy to train the 
stability of the knee. 
Clinical practice has been to usually wait at least six to eight weeks after the injury before 
surgically reconstructing the ACL. The reason for this is that it has been considered important 
to regain normal mobility in the injured knee before surgery. This routine is based on 
experiences from a time when ACL surgery was performed with an open technique (which is 
no longer used), and it was then found that stiffness in the operated knee was more common 
in those who underwent acute surgery. However, when delaying surgery there is a higher risk 
for other injuries to the knee, such as injuries to the cartilage and the meniscus.  
Traditionally, tendons used for reconstruction have been removed from the already injured 
leg. There have been indications that reconstruction using muscle tendons taken from the 
healthy leg has less harmful effects and a faster return to normal function after surgery, but no 
one has studied this further.  
The present dissertation is based on two randomised clinical trials and aims to answer 
questions regarding the timing of an ACL reconstruction and graft choice.  
Studies I–III 
In these studies, 70 highly active patients were randomly drawn to either early or delayed 
ACL reconstruction and compared for both subjective and objective measurements, with a 
focus on timing, and followed for two years after surgery. Early was defined within one week 
after the trauma and delayed when the patients had gained normal movement of the knee, 
which took 6–10 weeks. The difference between the groups regarding sick-leave days during 
the first year was also assessed as a measurement of indirect costs.  
No differences regarding outcome measurements or stiffness could be found between the 
groups, yet at the six-month follow-up, the early group had preserved more muscles around 
the knee. Additionally, the delayed group had significantly more sick-leave days within the 
first year, demonstrating that early ACL reconstruction is more cost-effective.  
Study IV 
A total of 140 patients were randomly drawn to either ACL reconstruction with a tendon 
from the already injured leg or from the healthy leg. The patients were followed for 24 
months after surgery. There were no comparable subjective differences between the two 
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groups, but the group in which the tendon was removed from the uninjured leg had 
symmetrical muscle strength after only six months, while the group in which the tendon was 
removed from the already damaged leg did not regain strength symmetry after two years. The 
group in which the tendon was removed from the uninjured leg was also significantly 
stronger when performing strength measurements.  
The dissertation shows that the previous belief that patients should wait a couple of months 
before an ACL reconstruction can be performed is not true; rather it can be performed safely 
immediately without any major risk of stiffness. From a societal perspective, it is cost-
effective to find the patients who need an ACL reconstruction as soon as possible. Using a 
tendon from the uninjured leg might have benefits regarding regaining early symmetrical 
strength and is a safe option. 
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